NDC 55150-443
regadenoson
Regadenoson
regadenoson is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Eugia Us Llc. The primary component is Regadenoson.
Product ID | 55150-443_b553eb2d-0c3f-444e-ad4c-282328683110 |
NDC | 55150-443 |
Product Type | Human Prescription Drug |
Proprietary Name | regadenoson |
Generic Name | Regadenoson |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2022-10-26 |
Marketing Category | ANDA / |
Application Number | ANDA216437 |
Labeler Name | Eugia US LLC |
Substance Name | REGADENOSON |
Active Ingredient Strength | 0 mg/mL |
Pharm Classes | Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |